CompletedPhase 3NCT00687908

Adapalene-Benzoy Peroxide (BPO) Gel in the Treatment of Acne Vulgaris as a 6-month Maintenance

Studying Anterior cutaneous nerve entrapment syndrome

Last synced from ClinicalTrials.gov

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
Galderma R&D
Principal Investigator
Diane Thiboutot, MD
Penn State College of Medicine, Hershey, PA
Intervention
Adapalene 0.1% / Benzoyl Peroxide 2.5% Gel(drug)
Enrollment
243 target
Eligibility
12-35 years · All sexes
Timeline
20082009

Study locations (30)

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT00687908 on ClinicalTrials.gov

Other trials for Anterior cutaneous nerve entrapment syndrome

Additional recruiting or active studies for the same condition.

See all trials for Anterior cutaneous nerve entrapment syndrome

← Back to all trials